Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidisha Singh

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Vaccine|June 28, 2016
Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strainsRichard C Condit, Anna-Lise Williamson, Rebecca Sheets, et al.
The Journal of Clinical Investigation|May 19, 2015
Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadthJordan R Willis, Gopal Sapparapu, Sasha Murrell, et al.
Vaccine: X|August 7, 2019
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessmentThomas P Monath, Patricia E Fast, Kayvon Modjarrad, et al.
Plos One|December 20, 2018
Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadthValentine U Chukwuma, Nurgun Kose, D Noah Sather, et al.
JCI Insight|August 3, 2016
Recognition of influenza H3N2 variant virus by human neutralizing antibodiesSandhya Bangaru, Travis Nieusma, Nurgun Kose, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Increased CSF volume, altered brain development and emotional reactivity after postnatal Zika virus infection in infant rhesus macaquesNisarg Desai, Kaitlyn Love, Alex van Schoor, et al.
Cell|October 22, 2016
Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus InfectionsIuliia Gilchuk, Pavlo Gilchuk, Gopal Sapparapu, et al.
Nature Medicine|October 2, 2023
AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaquesAmir Dashti, Sophia Sukkestad, Anna M Horner, et al.
The Journal of Clinical Investigation|June 15, 2023
Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapyYuyang Tang, Antoine Chaillon, Sara Gianella, et al.
Frontiers in Immunology|February 28, 2024
Drug-target identification in COVID-19 disease mechanisms using computational systems biology approachesAnna Niarakis, Marek Ostaszewski, Alexander Mazein, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Vaccine|June 28, 2016
Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strainsRichard C Condit, Anna-Lise Williamson, Rebecca Sheets, et al.
The Journal of Clinical Investigation|May 19, 2015
Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadthJordan R Willis, Gopal Sapparapu, Sasha Murrell, et al.
Vaccine: X|August 7, 2019
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessmentThomas P Monath, Patricia E Fast, Kayvon Modjarrad, et al.
Plos One|December 20, 2018
Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadthValentine U Chukwuma, Nurgun Kose, D Noah Sather, et al.
JCI Insight|August 3, 2016
Recognition of influenza H3N2 variant virus by human neutralizing antibodiesSandhya Bangaru, Travis Nieusma, Nurgun Kose, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Increased CSF volume, altered brain development and emotional reactivity after postnatal Zika virus infection in infant rhesus macaquesNisarg Desai, Kaitlyn Love, Alex van Schoor, et al.
Cell|October 22, 2016
Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus InfectionsIuliia Gilchuk, Pavlo Gilchuk, Gopal Sapparapu, et al.
Nature Medicine|October 2, 2023
AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaquesAmir Dashti, Sophia Sukkestad, Anna M Horner, et al.
The Journal of Clinical Investigation|June 15, 2023
Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapyYuyang Tang, Antoine Chaillon, Sara Gianella, et al.
Frontiers in Immunology|February 28, 2024
Drug-target identification in COVID-19 disease mechanisms using computational systems biology approachesAnna Niarakis, Marek Ostaszewski, Alexander Mazein, et al.
Pageof 4